A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.

Clinical trial NCT07258979 · RECRUITING

Trial details

NCT number: NCT07258979
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic Nasopharyngeal Carcinoma

Start date: 2025-11-05
Primary completion: 2028-02-01
Enrollment: 202

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.